Citat:
Ursprungligen postat av
Tobbex73
Vad går du på kompis? Förstår inte vad du vill ha fram. En länk med citat hade varit bra här.
35. Heron P, Cull A., Bourchier D and Lees H. Avoidable hazard to New Zealand children: case reports of haemorrhagic disease of the newborn. NZMJ 1988;101:507-8.
36. Hey, Edmund. Vitamin K - the debate continues. MIDIRS 1998;8(2):234-6.
37. Hilgartner, M. Vitamin K and the newborn. New Eng J Med 1993;329(13):957-8.
38. Hull D. Vitamin K and childhood cancer. BMJ 1992;305:326-7.
39. Israels l, Friesen E., Jansen A. and Israels E. Vitamin K1 increases sister chromatid exchange in vitro in human leukocytes and in vivo in fetal sheep cells: a possible role for 'vitamin K deficiency' in the fetus. Pediatr Res 1991;30:550-3.
40. Jorgensen F, Fielding P, Vinther S et al. Vitamin K to neonates. Peroral versus intramuscular administration. Acta Pediatr Scand 1991;80(3):304-7.
41. Klebanoff M, Read J, Mills J. et al. The risk of childhood cancer after neonatal exposure to vitamin K. New Eng J Med. 1993;329(13):905-8.
42. Koppe J, Pluim E and Olie K. Breastmilk, PCBs, dioxins and vitamin K deficiency: discussion paper. J Royal Soc. Medicine 1989;82:416-419 in, Donley, Joan. Vitamin K in relation to haemorrhagic disease of the newborn. NZCOM Journal Dec 1992.
43. Malia R, Preston F and Mitchell V. Evidence against vitamin K deficiency in normal neonates. Thromb Haemost 1980;44:159.
44. McKinney P, Juszczak E, Findlay E, Smith K. Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K. BMJ 1998;316:173-7.
45. McNinch A and Tripp J. Haemorrhagic disease of the newborn in the British Isles: a two year prospective study. BMJ 1991;303(6810):1105-1109.
46. McNinch A, Orme R and Tripp J. Haemorrhagic disease of the newborn returns. Lancet 1983;i:1089-90 (abstract).
47. McNinch A, Upton C, Samuels M et al. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child 1985;60:814-818.
48. Meyer T and Angus J. The effect of large doses of Synkavit in the newborn. Arch Dis Child 1956;31: 212-5 in, Ruby, C. Vitamin K: a historical perspective. MIDIRS 1997;7(3):362-4.
49. Mori P, Bisogni C, Odino S et al. (letter). Lancet 1977;ii:188.
50. Motohara K, Endo F and Matsuda I. Screening for late neonatal vitamin K deficiency by acarboxyprothrombin in dried blood spots. Arch Dis Child 1987;62:370-375.
51. Motz R. Late haemothorax after oral vitamin K. NZMJ 11 November 1992:459.
52. Muller A., van Doorm J and Hemker H. Heparin-like inhibitor of blood coagulation in normal newborn. Nature 1977;267:616-7.
53. New Ethicals Compendium; 3c: 303-304.
54. Nishiguchi T, Saga K, Sumimoto K. et al. Vitamin K prophylaxis to prevent neonatal vitamin K deficient intracranial haemorrhage in Shizuoka prefecture. Brit J Obstet Gynec 1996;103 (11):1078-84.
55. O'Connor M. and Addiego J. Use of oral vitamin K1 to prevent hemorrhagic disease of the newborn infant. J Pediatr 1986;108:616-9.
56. O'Connor M, Livingstone D, Hannah J. and Wilkins D. Vitamin K deficiency and breastfeeding. Am J Dis Child 1983;137:601-2
57. Olsen J, Hertz H, Blinkenberg K. et al. Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ 1994;308(6933):895-6 in, Greenwood, R. Vitamin K and childhood cancer. MIDIRS 1994;4(3):258-260
58. Olson J. Recommended dietary intakes (RDI) of vitamin K in humans. Am J Clin Nutr 1987;45:687-92.
59. Parker L, Cole M, Craft A, Hey E. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ 1998;316:189-93.
60. Passmore S, Draper G, Brownbill P, Kroll M. Case-control studies of relation between childhood cancer and neonatal vitamin K administration: retrospective case-control study. BMJ 1998;316:178-84.
61. Passmore S, Draper G, Brownbill P, Kroll M. Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer. BMJ 1998;316:184-9
62. Pizer B, Boyse J, Hunt L. and Mott M. Neonatal vitamin K administration and in vivo somatic mutation. Mutat Res 1995;347:135-9.
63. Roche Products Ltd. Position statement re: Konakion injection given orally.
64. Roche Products Ltd. New oral vitamin K formulation for newborns (press release). Welwyn Garden City, 30 Aug 1996.
65. Ruby Christine. Vitamin K prophylaxis: a historical perspective. MIDIRS 1997;7(3):362-4.
66. Shearer M. et al. Plasma vitamin K1 in mothers and their newborn babies. Lancet 1982:460-3 in, Hathaway, W. New insights on vitamin K. Hematol Oncol Clin North Am 1987;1(3):367-379.
67. Stevenson, J. The vitamin K conundrum. Maternity Alliance Action Newsletter July/August 1992.
68. Suzuki H, Nakao T and Hiraga K. Vitamin K deficiency in male rats fed diets containing butylated hydroxytoluene (BHT). Toxicol Appl Pharmacol 1979;50:261-6 in, Birkbeck J. Vitamin K prophylaxis in the newborn: a position statement of the Nutrition Committee of the Paediatric Society of New Zealand. NZMJ 1988;101:421-2.
69. Townsend C. The hemorrhagic disease of the newborn. Arch Pediatr 1894;11:559-562 in, Birkbeck J. Vitamin K prophylaxis in the newborn: a position statement of the Nutrition Committee of the Paediatric Society of New Zealand. NZMJ 1988;101:421-2.
70. Tripp J. and McNinch A. Haemorrhagic disease and vitamin K. Arch Dis Child 1987;62:436-7.
71. Tripp J and McNinch A. The vitamin K debacle: cut the Gordian knot but first do no harm. Arch Dis Child 1998;79:295-299.
72. Vail, B. Vitamin K prophylaxis and hemorrhagic disease of the newborn. ICEA Review 1985;9(3).
73. Van Doorm J and Hemker H. Vitamin K deficiency in the newborn (letter). Lancet 1977;ii:708-9.
74. Van Doorm J, Muller A. and Hemker, H. Heparin-like inhibitor, not vitamin-K deficiency, in the newborn (letter). Lancet 1977;i:852-3.
75. Vietti T, Murphy T, James J and Pritchard J. Observations on the prophylactic use of vitamin K in the newborn. J Pediatr 1960;56(3);343-6 (abstract).
76. Von Kries R. Neonatal vitamin K prophylaxis: the Gordian knot still awaits untying. BMJ 1998;316 (7126):161.
77. Von Kries R, Göbel U, Hachmeister A. et al. Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany. BMJ 1996;313(7051):199-203.
78. Von Kries R, Hachmeister A and Göbel U. Repeated oral vitamin K prophylaxis in West Germany: acceptance and efficacy. BMJ 1995;310 (6987):1097-8.
79. Von Kries R, Kreppel S, Becker A, Tangermann R and Göbel U. Acarboxyprothrombin activity after oral prophylactic vitamin K. Arch Dis Child 1987;62: 938-40.
80. Von Kries R, Shearer M and Göbel U. Vitamin K in infancy. Eur J Pediatr 1988;147:106-12.
81. Waddell W. and Guerry D. The role of vitamin K in the etiology, prevention and treatment of hemorrhage in the newborn infant. J Ped 1939;15:802 in, Ruby, C. Vitamin K prophylaxis: a historical perspective. MIDIRS 1997;7(3):362-4.
82. Whipple G. Hemorrhagic disease; antithrombin and prothrombin factors. Arch Intern Med. 1913;12:637-641 in, Birkbeck, J. Vitamin K prophylaxis in the newborn: a position statement of the Nutrition Committee of the Paediatric Society of New Zealand. NZMJ 1988;101:421-2.
83. Zipursky A. Vitamin K at birth. BMJ 1994;313(1051):179-180.